[HTML][HTML] A systematic review of cannabidiol trials in neurodevelopmental disorders

NF Parrella, AT Hill, PG Enticott, P Barhoun… - Pharmacology …, 2023 - Elsevier
Cannabis-derived compounds, such as cannabidiol (CBD) and delta-9-trans-
tetrahydrocannabinol (THC), are increasingly prescribed for a range of clinical indications …

Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression

G De Feo, AA Case, GB Crawford, D Hui, J To… - Supportive Care in …, 2023 - Springer
Purpose During the treatment of cancer, 18% of patients use cannabis for symptom
management. Anxiety, depression, and sleep disturbances are common symptoms in …

Cannabis use in attention–deficit/hyperactivity disorder (ADHD): a scoping review

AP Francisco, G Lethbridge, B Patterson… - Journal of psychiatric …, 2023 - Elsevier
Abstract Introduction Treatments for Adult ADHD include stimulants, two non-stimulant
medications, as well as cognitive-behavioral therapy (CBT). These pharmacological agents …

[HTML][HTML] Medicinal cannabis for psychiatry-related conditions: an overview of current Australian prescribing

EA Cairns, MJ Benson, MA Bedoya-Pérez… - Frontiers in …, 2023 - frontiersin.org
Objective: Evidence is accumulating that components of the Cannabis sativa plant may have
therapeutic potential in treating psychiatric disorders. Medicinal cannabis (MC) products are …

[HTML][HTML] Medicinal cannabis for paediatric developmental, behavioural and mental health disorders

D Efron, K Taylor - International Journal of Environmental Research and …, 2023 - mdpi.com
Parents of children with developmental, behavioural and mental health disorders are
increasingly asking whether medicinal cannabis might be a therapeutic option for their child …

[HTML][HTML] CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders–Results of a prospective, multicenter, randomized …

KR Müller-Vahl, A Pisarenko, N Szejko, M Haas… - Psychiatry …, 2023 - Elsevier
Preliminary data suggest that cannabis-based medicines might be a promising new
treatment for patients with Tourette syndrome (TS)/chronic tic disorders (CTD) resulting in an …

[HTML][HTML] FAAH rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine

HH Silva, V Tavares, BV Neto, F Cerqueira, R Medeiros… - Genes, 2023 - mdpi.com
Gene variation linked to physiological functions is recognised to affect elite athletic
performance by modulating training and competition-enabling behaviour. The fatty acid …

Cross-disorder GWAS meta-analysis of endocannabinoid DNA variations in major depressive disorder, bipolar disorder, attention deficit hyperactivity disorder, autism …

HK Kim, VF Gonçalves, MI Husain, DJ Müller… - Psychiatry …, 2023 - Elsevier
The endocannabinoid system (ECS) is implicated in multiple mental disorders. In this study,
we explored DNA variations in the ECS across major depressive disorder (MDD), bipolar …

The study of rs324420 (C385A) polymorphism of the FAAH gene of the endocannabinoid system in patients with epilepsy and ADHD

LH Anvar, A Alejafar, SE Moosavi, S Charsouei… - Epilepsy Research, 2023 - Elsevier
The endocannabinoid (eCB) system regulates many physiological functions in the central
nervous system. Fatty acid amide hydrolase (FAAH) is an essential enzyme in the eCB …

Cannabis–A state of the art about the millenary plant: Part I

NA dos Santos, W Romão - Forensic Chemistry, 2023 - Elsevier
Cannabis is a plant that has several evolutionary aspects related to its use and application
throughout history. Due to simple cultivation, it is present in all hemispheres of the earth and …